The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 3,401–3,500 of 31,469
Kikuchi, M., Abe, N., Kato, M., Terao, S., Mimori, N., & Tachibana, H. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.006 · Cited by 94
Yang, Y., Lü, H., Zhang, J., Yu, H. Y., Wang, H. W., Zhang, M., & Cianflone, K. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803173 · Cited by 94
Fabbrini, E., DeHaseth, D., Deivanayagam, S., Mohammed, B. S., Vitola, B. E., & Klein, S. (2008) · Obesity · doi:10.1038/oby.2008.494 · Cited by 94
Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study
SIMONE, G. D., Devereux, R. B., Chinali, M., Roman, M. J., Barac, A., Panza, J. A., Lee, E. T., & Howard, B. V. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328347a093 · Cited by 94
Strong Association between Gallstones and Cardiovascular Disease
Méndez‐Sánchez, N., Bahena-Aponte, J. A., Chávez-Tapia, N. C., Motola‐Kuba, D., Sánchez-Lara, K., Ponciano-Radriguez, G., Ramos, M. H., & Uribe, M. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41214.x · Cited by 93
Quercetin enhances adiponectin secretion by a PPAR-γ independent mechanism
Wein, S., Behm, N., Petersen, R. K., Kristiansen, K., & Wolffram, S. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.004 · Cited by 95
Incretins and the development of type 2 diabetes
Meier, J. J., & Nauck, M. A. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0034-7 · Cited by 96
Sjögren, P., Basu, S., Rosell, M., Silveira, A. M. V., Fairé, U. D., Vessby, B. O., Hamsten, A., Hellénius, M.-L., & Fisher, R. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000190675.08857.3d · Cited by 94
Kawamoto, R., Kohara, K., Kusunoki, T., Tabara, Y., Abe, M., & Miki, T. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-117 · Cited by 94
Li, S., Chang, C., Fu-Ying, M. A., et al. (2009) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(09)60034-9 · Cited by 94
Circulating interleukin-6 concentrations during and after gestational diabetes mellitus
Morisset, A., Dubé, M., Côté, J. A., Robitaille, J., Weisnagel, S. J., & Tchernof, A. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01094.x · Cited by 94
Glucose and insulin responses to whole grain breakfasts varying in soluble fiber, β-glucan
Kim, H., Stote, K. S., Behall, K. M., Spears, K. E., Vinyard, B. T., & Conway, J. M. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0778-3 · Cited by 94
Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients
Zhang, D., Zhang, L., Zheng, Y., Yue, F., Russell, R., & Zeng, Y. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.017 · Cited by 94
Nobili, V., Manco, M., Ciampalini, P., Ciommo, V. M. D., Vito, R. D., Piemonte, F., Comparcola, D., Guidi, R., & Marcellini, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02288 · Cited by 94
Ramsay, S. E., Whincup, P. H., Shaper, A. G., & Wannamethee, S. G. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj217 · Cited by 94
Yokoyama, H., Emoto, M., Fujiwara, S., Motoyama, K., Morioka, T., Komatsu, M., Tahara, H., Koyama, H., Shoji, T., Inaba, M., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031374 · Cited by 94
Menopausal Hot Flashes and Carotid Intima Media Thickness Among Midlife Women
Thurston, R. C., Chang, Y., Barinas‐Mitchell, E., Jennings, J. R., Landsittel, D., Santoro, N. F., von Känel, R., & Matthews, K. A. (2016) · Stroke · doi:10.1161/strokeaha.116.014674 · Cited by 95
Serum magnesium and the risk of prediabetes: a population-based cohort study
Kieboom, B. C. T., Ligthart, S., Dehghan, A., Kurstjens, S., de Baaij, J. H. F., Franco, O. H., Albert Hofman, D., Zietse, R., Stricker, B. H. C., & Hoorn, E. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4224-4 · Cited by 96
Sex-Related Differences Between Adiponectin and Insulin Resistance in Schoolchildren
Tsou, P.-L., Jiang, Y., Chang, C.-C., Wei, J., Sung, F.-C., Lin, C., Chiang, C.-C., Tai, T. Y., & Chuang, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.308 · Cited by 94
Role of Calpain-10 Gene Variants in Familial Type 2 Diabetes in Caucasians
Elbein, S. C., Chu, W. S., Ren, Q., Hemphill, C., Schay, J., Cox, N. J., Hanis, C. L., & Hasstedt, S. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8210 · Cited by 94
Dubé, M. P., Edmondson‐Melançon, H., Qian, D., Aqeel, R., Johnson, D., & Buchanan, T. A. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200106010-00006 · Cited by 95
Dell’Omo, G., Penno, G., Giorgi, D., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33906 · Cited by 94
Genome-wide association with diabetes-related traits in the Framingham Heart Study
Meigs, J. B., Manning, A. K., Fox, C. S., Florez, J. C., Liu, C., Cupples, L. A., & Dupuis, J. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s16 · Cited by 94
Psychological implications of infertility in women with polycystic ovary syndrome
Tan, S., Hahn, S., Benson, S., Janssen, O. E., Dietz, T., Kimmig, R., Hesse-Hussain, J., Mann, K., Schedlowski, M., Arck, P. C., et al. (2008) · Human Reproduction · doi:10.1093/humrep/den227 · Cited by 128
Aberg, J. A., Tebas, P., Overton, E. T., Gupta, S. K., Sax, P. E., LANDAY, A. L., Falcon, R., Ryan, R. J., & Rosa, G. D. L. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0327 · Cited by 92
The association of serum chemerin level with risk of coronary artery disease in Chinese adults
Yan, Q., Zhang, Y., Hong, J., Gu, W., Dai, M., Shi, J., Zhai, Y., Wang, W., Li, X., & Ning, G. (2011) · Endocrine · doi:10.1007/s12020-011-9550-6 · Cited by 95
de Luis, D. A., Díaz-Soto, G., Izaola, O., & Romero, E. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.02.010 · Cited by 94
Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles
Pearce, M. S., McConnell, J. C., Potter, C., Barrett, L. M., Parker, L., Mathers, J. C., & Relton, C. L. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys020 · Cited by 93
Das, K., Sarkar, R., Ahmed, S. M., Mridha, A. R., Mukherjee, P. S., Das, K., Dhali, G. K., Santra, A. K., & Chowdhury, A. (2011) · Hepatology · doi:10.1002/hep.24694 · Cited by 92
Rahimlou, M., Yari, Z., Hekmatdoost, A., Alavian, S. M., & Keshavarz, S. A. (2016) · Hepatitis Monthly · doi:10.5812/hepatmon.34897 · Cited by 93
Ebrahimi‐Mameghani, M., Sadeghi, Z., Farhangi, M. A., Vaghef‐Mehrabany, E., & Aliashrafi, S. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.004 · Cited by 94
Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients
Hu, Z., Chen, J., Sun, X., Wang, L., & Wang, A. (2019) · Medicine · doi:10.1097/md.0000000000014970 · Cited by 94
Liu, L., Xia, R., Song, X., Zhang, B., He, W., Zhou, X., Li, S., & Yuan, G. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13371 · Cited by 100
Ballestri, S., Mantovani, A., Baldelli, E., Lugari, S., Maurantonio, M., Nascimbeni, F., Marrazzo, A., Romagnoli, D., Targher, G., & Lonardo, A. (2021) · Diagnostics · doi:10.3390/diagnostics11010098 · Cited by 99
Undiagnosed Diabetes and Pre-Diabetes in Health Disparities
Fisher‐Hoch, S. P., Vatcheva, K. P., Rahbar, M. H., & McCormick, J. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133135 · Cited by 102
Bertinato, J., Xiao, C. W., Ratnayake, W. M. N., Fernandez, L., Lavergne, C., Wood, C. M., & Swist, E. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.25974 · Cited by 94
Kuate, D., Kengne, A. P., Cabral, B. N. P., Azantsa, B. G. K., & Muda, W. A. M. W. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0051-0 · Cited by 94
Neck circumference: a useful screening tool of cardiovascular risk in children
Androutsos, O., Grammatikaki, E., Moschonis, G., Roma‐Giannikou, E., Chrousos, G. P., Μanios, Y., & Kanaka‐Gantenbein, C. (2012) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00052.x · Cited by 93
Hata, A., Doi, Y., Ninomiya, T., Mukai, N., Hirakawa, Y., Hata, J., Ozawa, M., Uchida, K., Shirota, T., Kitazono, T., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12250 · Cited by 93
Fraser, A., Abel, R., Lawlor, D. A., Fraser, D., & Elhayany, A. (2008) · Diabetologia · doi:10.1007/s00125-008-1049-1 · Cited by 93
Charles, C. P., Yuskavage, J., Carlson, O. D., John, M., Tagalicud, A., Maggio, M. G., Muller, D. C., Egan, J. M., & Basaria, S. S. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181857979 · Cited by 93
Salazar, M. R., Carbajal, H. A., Espeche, W. G., Aizpurúa, M., Maciel, P. M., & Reaven, G. M. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.10.012 · Cited by 93
Carulli, L., Canedi, I., Rondinella, S., Lombardini, S., Ganazzi, D., Fargion, S. R., Palma, M. D., Lonardo, A., Ricchi, M., Bertolotti, M., et al. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.03.005 · Cited by 93
Impact of Treating Acromegaly First with Surgery or Somatostatin Analogs on Cardiomyopathy
Colao, A., Pivonello, R., Galderisi, M., Cappabianca, P., Auriemma, R. S., Galdiero, M., Cavallo, L. M., Esposito, F., & Lombardi, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0299 · Cited by 93
Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes
Nielsen, L. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03460-4 · Cited by 93
Miyatake, N., Nishikawa, H., Morishita, A., Kunitomi, M., Wada, J., Suzuki, H., Takahashi, K., Makino, H., Kira, S., & Fujii, M. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00129-8 · Cited by 93
Race–ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN)
Khan, U. I., Wang, D., Sowers, M. R., Mancuso, P., Everson‐Rose, S. A., Scherer, P. E., & Wildman, R. P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.02.005 · Cited by 91
Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status
Houde, A., Guay, S., Desgagné, V., Hivert, M., Baillargeon, J., St-Pierre, J., Perron, P., Gaudet, D., Brisson, D., & Bouchard, L. (2013) · Epigenetics · doi:10.4161/epi.26554 · Cited by 90
Indinavir impairs endothelial function in healthy HIV-negative men
Shankar, S. S., Dubé, M. P., Gorski, J. C., Klaunig, J. E., & Steinberg, H. O. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.06.005 · Cited by 93
Hu, H. Z., Kan, H., Kearney, G. D., & Xu, X. (2014) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2014.09.085 · Cited by 96
Obstructive Sleep-Disordered Breathing and Fasting Insulin Levels in Nonobese Children
Kaditis, A. G., Alexopoulos, E. Ι., Damani, E., Καραδόντα, Ι., Kostadima, E., Tsolakidou, A., Gourgoulianis, K. I., & Syrogiannopoulos, G. A. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20306 · Cited by 93
Tarkun, İ., Çetinarslan, B., Türemen, E., Cantürk, Z., & Biyikli, M. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.122 · Cited by 95
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease
Centis, E., Moscatiello, S., Bugianesi, E., Bellentani, S., Fracanzani, A. L., Calugi, S., Petta, S., Grave, R. D., & Marchesini, G. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.031 · Cited by 91
Hackman, R. M., Havel, P. J., Schwartz, H. J., Rutledge, J. C., Watnik, M., Noceti, E. M., Stohs, S. J., Stern, J. S., & Keen, C. L. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803283 · Cited by 94
Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy
Tock, L., do Prado, W. L., Caranti, D. A., Cristofalo, D. M. J., Lederman, H. M., Fisberg, M., Siqueira, K. L. O., Stella, S. R. G., Antunes, H. K. M., Cintra, I. P., et al. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000243872.86949.95 · Cited by 93
Gannagé‐Yared, M., Yaghi, C., Habre, B., Khalifé, S., Noun, R. J., Germanos-Haddad, M., & Trak-Smayra, V. E. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0797 · Cited by 93
Relationship between Vitamin D Receptor gene polymorphisms and the components of metabolic syndrome
Schuch, N. J., Garcia, V. C., Vívolo, S. R. G. F., & Martini, L. A. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-96 · Cited by 92
Thalacker‐Mercer, A. E., Ingram, K. H., Guo, F., Ilkayeva, O., Newgard, C. B., & Garvey, W. T. (2013) · Diabetes · doi:10.2337/db13-0396 · Cited by 95
Huang, R.-C., Mori, T. A., Burke, V., Newnham, J., Stanley, F. J., Landau, L. I., Kendall, G. E., Oddy, W. H., & Beilin, L. J. (2009) · Diabetes Care · doi:10.2337/dc08-1917 · Cited by 93
Cade, W. T., Reeds, D., Mondy, K., Overton, E. T., Grassino, J., Tucker, S., Bopp, C., Laciny, E., Hubert, S., Lassa‐Claxton, S., et al. (2010) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00801.x · Cited by 98
Pasiakos, S. M., Lieberman, H. R., & Fulgoni, V. L. I. (2015) · Journal of Nutrition · doi:10.3945/jn.114.205203 · Cited by 96
Wilkin, T. J., Metcalf, B. S., Murphy, M. J., Kirkby, J., Jeffery, A., & Voss, L. D. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3468 · Cited by 95
Self-reported economic difficulties and coronary events in men: evidence from the Whitehall II study
Ferrie, J. E., Martikainen, P., Shipley, M. J., & Marmot, M. G. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi063 · Cited by 91
Dietary patterns, insulin sensitivity and inflammation in older adults
Anderson, A. L., Harris, T. B., Tylavsky, F. A., Perry, S. E., Houston, D. K., Lee, J. S., Kanaya, A. M., Sahyoun, N. R., & Study, F. T. H. A. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.162 · Cited by 93
Bernsmeier, C., Weisskopf, D. M., Pflueger, M. O., Mosimann, J., Campana, B., Terracciano, L., Beglinger, C., Heim, M. H., & Cajochen, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143293 · Cited by 98
The relation of insulin resistance syndromes to risk of cardiovascular disease.
Nesto, R. W. (2003) · PubMed · Cited by 93
Prevalence of Dyslipidemia and Associated Factors in Obese Children and Adolescents
Elmaoğulları, S., Tepe, D., Uçaktürk, S. A., Kara, F. K., & Demirel, F. (2015) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1867 · Cited by 96
Pratchayasakul, W., Sa‐nguanmoo, P., Sivasinprasasn, S., Pintana, H., Tawinvisan, R., Sripetchwandee, J., Kumfu, S., Chattipakorn, N., & Chattipakorn, S. C. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.04.023 · Cited by 94
Lemos, V., de Oliveira, R. M., Naia, L., Szegő, É. M., Ramos, E., Pinho, S., Magro, F., Cavadas, C., Rego, A. C., Costa, V., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx298 · Cited by 94
Overweight and obesity and the burden of disease and disability in elderly men
Wannamethee, S. G., Shaper, A. G., Whincup, P. H., & Walker, M. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802775 · Cited by 94
Cheng, L. S.-C., Davis, R. C., Raffel, L. J., Xiang, A. H., Wang, N., Quiñones, M., Wen, P.-Z., Toscano, E., Diaz, J., Pressman, S. D., et al. (2001) · Circulation · doi:10.1161/hc3601.096729 · Cited by 93
The role of hepassocin in the development of non-alcoholic fatty liver disease
Wu, H.-T., Lu, F.-H., Ou, H.-Y., Su, Y.-C., Hung, H.-C., Wu, J.-S., Yang, Y.-C., Wu, C.-L., & Chang, C.-J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.004 · Cited by 92
Petta, S., Cammà, C., Marco, V. D., Macaluso, F. S., Maida, M. F., Pizzolanti, G., Belmonte, B., Cabibi, D., Stefano, R. D., Ferraro, D., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02453.x · Cited by 94
Akter, S., Eguchi, M., Kuwahara, K., Kochi, T., Ito, R., Kurotani, K., Tsuruoka, H., Nanri, A., Kabe, I., & Mizoue, T. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.03.008 · Cited by 92
Li, M., Fisette, A., Zhao, X.-Y., Deng, J.-Y., Mi, J., & Cianflone, K. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.44 · Cited by 92
Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus
Aslan, M., Çelik, Ö., Çelik, N., Türkçüoğlu, İ., Yılmaz, E., Karaer, A., Şimşek, Y., Çelik, E., & Aydın, S. (2011) · Endocrine · doi:10.1007/s12020-011-9577-8 · Cited by 92
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus
Santilli, F., Formoso, G., Sbraccia, P., Averna, M. R., Miccoli, R., Fulvio, P. D., Ganci, A., Pulizzi, N., Lattanzio, S., Ciabattoni, G., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03742.x · Cited by 91
Lower bone mass in prepubertal overweight children with prediabetes
Pollock, N. K., Bernard, P. J., Wenger, K., Misra, S., Gower, B. A., Allison, J. D., Zhu, H., & Davis, C. L. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.184 · Cited by 91
Adiposity distribution influences circulating adiponectin levels
Guenther, M. A., James, R. G., Marks, J., Zhao, S., Szabó, A., & Kidambi, S. (2014) · Translational research · doi:10.1016/j.trsl.2014.04.008 · Cited by 94
Mager, D. R., Rivera‐Íñiguez, I., Gilmour, S. M., & Yap, J. Y. K. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113501201 · Cited by 93
Machado, M. V., Coutinho, J., Carepa, F., Costa, A., Proença, H., & Cortez‐Pinto, H. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835609b0 · Cited by 92
Nelson, D. R., Benhamou, Y., Chuang, W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.062 · Cited by 92
Hara, T., Fujiwara, H., Nakao, H., Mimura, T., Yoshikawa, T., & Fujimoto, S. (2005) · European Journal of Applied Physiology · doi:10.1007/s00421-005-1374-8 · Cited by 93
A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study
Huh, J. H., Ahn, S. V., Koh, S. B., Choi, E. H., Kim, J., Sung, K., Kim, E. J., & Park, J. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143560 · Cited by 93
Effects of air pollution exposure on glucose metabolism in Los Angeles minority children
Toledo‐Corral, C. M., Alderete, T. L., Habre, R., Berhane, K. T., Lurmann, F. W., Weigensberg, M. J., Goran, M. I., & Gilliland, F. D. (2016) · Pediatric Obesity · doi:10.1111/ijpo.12188 · Cited by 92
Smoking cessation and outcome after ischemic stroke or TIA
Epstein, K. A., Viscoli, C. M., Spence, J. D., Young, L. H., Inzucchi, S. E., Gorman, M., Gerstenhaber, B. J., Guarino, P., Dixit, A. K., Furie, K. L., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004524 · Cited by 92
Francisqueti‐Ferron, F. V., Minatel, I. O., Ferron, A. J. T., et al. (2017) · Nutrients · doi:10.3390/nu9121299 · Cited by 92
Recent research trends and updates on nonalcoholic fatty liver disease
Yoo, J., Kim, W. K., Kim, M. Y., Jun, D. W., Kim, S. G., Yeon, J.-E., Lee, J. W., Cho, Y. K., Park, S. H., & Sohn, J. H. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.0037 · Cited by 94
Rezazadeh, L., Gargari, B. P., Jafarabadi, M. A., & Alipour, B. (2019) · Nutrition · doi:10.1016/j.nut.2018.12.011 · Cited by 91
Yun, Y., Kim, H.-N., Lee, E., Ryu, S., Chang, Y., Shin, H. C., Kim, H., Kim, T. H., Yoo, K., & Kim, H. Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213692 · Cited by 97
Ichijo, T., Ueshiba, H., Nawata, H., & Yanase, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0486 · Cited by 97
Rumanova, V. S., Okuliarová, M., & Zeman, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155478 · Cited by 100
Li, Z., Gao, Z., Sun, T., Zhang, S., Yang, S., Zheng, M., & Shen, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1098570 · Cited by 100
He, H., Xie, Y., Chen, Q., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02604-z · Cited by 92
The metabolic profile in patients with skin tags
Sarı, R., Akman, A., Alpsoy, E., & Balcı, M. K. (2009) · Clinical and Experimental Medicine · doi:10.1007/s10238-009-0086-5 · Cited by 93
Altay, U., Gürgan, C. A., & Ağbaht, K. (2012) · Journal of Periodontology · doi:10.1902/jop.2012.110646 · Cited by 93
Adegboye, A. R. A., Anderssen, S. A., Froberg, K., Sardinha, L. B., Heitmann, B. L., Steene‐Johannessen, J., Kolle, E., & Andersen, L. B. (2010) · British Journal of Sports Medicine · doi:10.1136/bjsm.2009.068346 · Cited by 92
Rodríguez-Rodríguez, C., Torres, N., Gutierrez-Uribe, J. A., Noriega, L. G., Torre-Villalvazo, I., Leal‐Díaz, A. M., Antunes‐Ricardo, M., Marquez-Mota, C. C., Ordáz, G., Chávez-Santoscoy, R. A., et al. (2014) · Food & Function · doi:10.1039/c4fo01092b · Cited by 97
Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity
Chan, D. C., Watts, G. F., Mori, T. A., Barrett, P. H. R., Beilin, L. J., & Redgrave, T. G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01001.x · Cited by 90
Giordanino, C., Bugianesi, E., Smedile, A., Ciancio, A., Abate, M. L., Olivero, A., Pellicano, R., Cassader, M., Gambino, R., Bo, S., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02002.x · Cited by 90
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
